120 related articles for article (PubMed ID: 31564571)
1. Shp2 expression is upregulated in cervical cancer, and Shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells.
Cao M; Gao D; Zhang N; Duan Y; Wang Y; Mujtaba H; Wang Y
Pathol Res Pract; 2019 Nov; 215(11):152621. PubMed ID: 31564571
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma.
Hu Z; Fang H; Wang X; Chen D; Chen Z; Wang S
Oncol Rep; 2014 Jul; 32(1):205-12. PubMed ID: 24858400
[TBL] [Abstract][Full Text] [Related]
3. Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798.
Yang X; Tang C; Luo H; Wang H; Zhou X
Oncotarget; 2017 Apr; 8(14):23664-23674. PubMed ID: 28423588
[TBL] [Abstract][Full Text] [Related]
4. Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
Tang C; Luo H; Luo D; Yang H; Zhou X
Oncol Rep; 2018 Feb; 39(2):611-618. PubMed ID: 29207183
[TBL] [Abstract][Full Text] [Related]
5. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101
[TBL] [Abstract][Full Text] [Related]
6. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
[TBL] [Abstract][Full Text] [Related]
7. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
Feng LL; Shen FR; Zhou JH; Chen YG
Gene; 2019 May; 696():105-112. PubMed ID: 30738960
[TBL] [Abstract][Full Text] [Related]
8. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
9. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
10. The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK.
Yu M; Xu C; Zhang H; Lun J; Wang L; Zhang G; Fang J
Biochem Biophys Res Commun; 2021 Jul; 563():1-7. PubMed ID: 34052504
[TBL] [Abstract][Full Text] [Related]
11. Enhancer of mRNA Decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical Cancer by alleviating DNA damage.
Wu X; Zhong Y; Chen Q; Zhang X; Zhang H
Hereditas; 2020 Oct; 157(1):41. PubMed ID: 33054858
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro.
Xie H; Huang S; Li W; Zhao H; Zhang T; Zhang D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):234-42. PubMed ID: 24439919
[TBL] [Abstract][Full Text] [Related]
13. Selective activation of SHP2 activity by cisplatin revealed by a novel chemical probe-based assay.
Kuo CC; Chu CY; Lin JJ; Lo LC
Biochem Biophys Res Commun; 2010 Jan; 391(1):230-4. PubMed ID: 19909727
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
15. Combination of Sodium Cantharidinate with Cisplatin Synergistically Hampers Growth of Cervical Cancer.
Chen X; Zhou M; Fan W; Yang M; Yang L
Drug Des Devel Ther; 2021; 15():171-183. PubMed ID: 33469269
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
18. Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.
Rataj O; Haedicke-Jarboui J; Stubenrauch F; Iftner T
Int J Cancer; 2019 May; 144(9):2330-2338. PubMed ID: 30421459
[TBL] [Abstract][Full Text] [Related]
19. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
[TBL] [Abstract][Full Text] [Related]
20. Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells.
Sun X; Zhang J; Wang Z; Ji W; Tian R; Zhang F; Niu R
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
